Retatrutide is a synthetic triple agonist peptide designed to target GIP, GLP-1, and glucagon receptors. It has attracted significant interest in metabolic and weight management research due to its potential impact on glucose homeostasis, appetite regulation, and energy expenditure.
In laboratory studies, Retatrutide is valued for its high receptor affinity, multi-pathway action, and consistent bioactivity, making it a key compound in advanced metabolic and endocrine research protocols.
- Purity: ≥ 99 % (HPLC verified)
- Form: Lyophilized peptide powder
- Quantity: mg per vial vary according to product chosen
- Storage: Store lyophilized peptide at −20 °C; once reconstituted, refrigerate at 2–8 °C for up to 28 days
- Intended Use: For laboratory research only; not for human or animal consumption
Key Features:
- Triple receptor agonist for advanced metabolic research
- Most effective weight loss according to phase 3 trials research
- High purity and stability for consistent lab performance
- Manufactured in a cGMP-compliant facility
- COA available upon request
Benefits
- Superior weight loss compared to GLP-1 agonists alone
- Improves blood sugar control and reduces insulin resistance
- Offers cardiometabolic benefits including improved cholesterol levels
- Potential neuroprotective effects
- Mechanism of Action
Disclaimer: This product is strictly intended for laboratory research use only. It is not for human consumption, medical use, or diagnostic applications.
